Resumo

QUIROZ, Deymar; QUIROZ, Deynalia; BOGNANNO, Francisco J.  e  MARIN, Melania. PREVALENCE OF METABOLIC SYNDROME AND RISK FACTORS KARIÑA ETNIC, BOLIVAR STATE, VENEZUELA. Rev Cient Cienc Méd [online]. 2018, vol.21, n.1, pp.7-13. ISSN 2077-3323.

Metabolic Syndrome includes the association of risk factors: hypertension, obesity, dyslipidemia and insulin resistance, which increases the possibility of developing cerebrovascular, cardiovascular and diabetes diseases. General objective: To determine the prevalence of the Metabolic Syndrome and its risk factors in individuals of the Kariña ethnic group. May 2013 - May 2014. Methods: An observational, descriptive study and cross section study was conducted; with a universe of 203 individuals, and a sample of 120 individuals (18-85 years) of the Kariña ethnic group of the Community of Mayagua, Bolívar State, Venezuela. In all participants, the lipid profile was analyzed with the colorimetric method. The glycemia was quantified with a glucometer prior to fasting for 12 hours.The diagnostic criteria of the International Diabetes Federation, the Latin American Diabetes Association and theAdultTreatment Panel III were used. Results: the prevalence of the metabolic syndrome was 46,67% according to the International Diabetes Federation, 39,17% Latin American Diabetes Association, and 38.33% AdultTreatment Panel II, the Kappa (k) concordance between Adult Treatment Panel III and International Diabetes Federation indicates a considerable concordance force, said Index between Adult Treatment Panel III and Latin American Diabetes Association denotes an almost perfect match strength as does the index between Latin American Diabetes Association and International Diabetes Federation. Conclusion: A high prevalence of metabolic syndrome was found by both the Latin American Diabetes Association, International Diabetes Federation and Adult Treatment Panel III criteria, with predominance in the female gender and individuals over 50 years old.

Palavras-chave : obesity; hyperglycemia and dyslipidemia.

        · resumo em Espanhol     · texto em Espanhol | Inglês     · Inglês ( pdf ) | Espanhol ( pdf )